Wisconsin Bill Aims to Combat Post-Incarceration Overdoses with Medicaid Funds
Table of Contents
A new legislative effort in Wisconsin seeks to address the alarmingly high rate of overdose deaths and suicide among individuals recently released from prison by leveraging federal medicaid dollars for pre-release substance use disorder treatment. The bill, championed by state Sen. Jesse James, proposes a proactive approach to a crisis that costs the state millions and claims hundreds of lives annually.
the Crisis Behind Prison Walls
Every year, a devastating number of individuals die from opioid overdoses within three months of leaving incarceration, with suicide representing another significant cause of post-release mortality. This vulnerability is a reality keenly understood by Sen.James, who has openly shared his personal experience with addiction and incarceration. “I relapsed several times in my sobriety experience. It’s not as easy as what people think, especially if you don’t have the addiction and recovery experiences,” he stated, emphasizing the ongoing struggle for sustained recovery. He recognizes how easily he could have become another statistic.
The cyclical nature of addiction frequently leads to recidivism, job instability, mental health crises, hospitalizations, and ultimately, death. Recognizing this pattern, the proposed legislation aims to interrupt this cycle by providing critical support before and promptly after release. The bill’s key provisions include:
- Case management
- medication for behavioral health therapy
- A 30-day supply of prescription medication upon release.
This model mirrors prosperous programs implemented in 19 other states, requiring the Wisconsin Department of Health Services to submit a Section 1115 Medicaid waiver to secure federal matching funds for incarcerated individuals.
Crucially, the bill is designed to avoid triggering opposition from those wary of Medicaid expansion. Sen. James emphasized that the legislation would only apply to individuals already eligible for Medicaid prior to their incarceration. He also pointed out that Wisconsin taxpayers already contribute to the federal Centers for Medicare and Medicaid Services.
A Growing Need: Substance Use in Wisconsin Prisons
The urgency of this legislation is underscored by the prevalence of substance use disorders within the Wisconsin prison system. Data reveals that at least 63% of incarcerated individuals struggle with substance use, meaning that, of the roughly 667 people released each month between August 2024 and August 2025, at least 420 are at heightened risk of overdose.
A 2021 report from the Wisconsin Department of Corrections documented 276 prison releases followed by a fatal opioid overdose within one year, with an additional 754 individuals requiring hospitalization for opioid-related emergencies. As of September, 1,225 incarcerated people are enrolled in substance use treatment programs, but a staggering 11,596 remain on a monthly waitlist. .
Concerns Over Mental Health Coverage
While the bill enjoys broad bipartisan support,concerns have been raised regarding its limited scope. At a public hearing on November 4th, rick Schultz voiced opposition, not to supporting those with substance use disorder, but because the bill fails to adequately address the needs of individuals with mental illness.
Schultz shared a personal story about his son, who suffers from bipolar disorder and schizophrenia, and repeatedly cycles through the Milwaukee County Jail without consistent access to necessary psychiatric medications. He recounted receiving a prescription for antacids instead of his son’s crucial psychotropic medication upon release, highlighting a systemic failure in providing adequate medical oversight.”There’s tacit approval for treating substance use disorder and then silence related to mental illness. That is discrimination,” Schultz stated.
Sen. James acknowledged the validity of these concerns, reiterating his belief that individuals experiencing mental health crises “don’t necessarily belong in our jails and prisons.” However, he explained that the current Medicaid waiver is narrowly focused, limiting the scope of covered services. “Our hands are tied in how we can use those dollars,” he saeid, “But if we focus on the pre-release timeframe and the vrey short-term period afterwards, we’ll see valuable gains that can also contribute to mental health relief.”
The bill is currently scheduled to come to the floor for a vote as early as November 18th, representing a critical step towards addressing the devastating consequences of post-incarceration substance use and, hopefully, paving the way for broader reforms to address the interconnected challenges of addiction and mental health within the Wisconsin criminal justice system.
